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Background: Catamenial psychosis is a
rare subtype of menstrual psychosis which
shares clinical features with bipolar disorder.
It is characterized by acute, periodic, and
remitting psychosis associated with the
onset of a woman’s menstrual cycle. The
pathophysiology, while incompletely
understood, is hypothesized to involve the
hypothalamic-pituitary-ovarian axis and
management includes menstrual suppression.
Treatment typically yields prompt and
dramatic symptom resolution. Consent was
obtained from the patient.

recurring symptoms frequently aligned with
the initiation of her menstrual cycle, and
she had experienced improvement in her
symptoms in the past while on OCPs. Due to
her recurring, cyclical episodes of psychosis
with a temporal relationship to the onset of
menstruation, the presumptive diagnosis
of catamenial psychosis was made and the
patient was referred for menstrual suppression.

Methods: A 40 year old female presented
for evaluation of chronic, cyclical episodes
of abnormal mentation with associated
visual and auditory hallucinations. She had
previously been diagnosed with Bipolar
1 Disorder and despite medical therapy
continued to experience episodes psychosis
which included auditory hallucinations.
However, given her new onset visual
hallucinations, she was admitted for further
workup.

Conclusion: Catamenial psychosis is rare,
but likely underrecognized. All women of
reproductive age with symptoms of psychosis
should be screened for a correlation with their
menstrual cycle as treatment results in drastic
and prompt improvement. 

Results: Neurology and Psychiatric services
were consulted and a thorough medical and
neurologic workup including brain MRI,
lumbar puncture, electrolyte, and infectious
studies failed to reveal an organic cause of
her symptoms. Further history revealed her
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Conclusion: RA patients with unprovoked
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ASCVD. RA patients with unprovoked VTE
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After multivariable adjustment, we found
that patients with an unprovoked VTE had a

Type: Original Research
Objective: To determine the risk of
subsequent ASCVD in RA patients with

  
Methods:      
participation in FORWARD from 1998
through 2018 were assessed for incident
nonfatal and fatal ASCVD (myocardial
infarction and stroke) validated from hospital/
death records. We excluded patients with
prior VTE/ASCVD and active cancer. We
 
     
VTE. We calculated event rates and estimated
the risk of subsequent ASCVD in these
patients compared to patients with no
history of VTE and ASCVD by using Cox
proportional hazards with adjustment for
sociodemographics, comorbidities, and RA
severity measures.
Results: In 25,070 RA patients with no
VTE or ASCVD and 506 patients with
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(IQR) 4.7 (2.4-8.9) years of follow-up. The
incidence rate (95% CI) of ASCVD was
higher in patients with VTE vs. patients
  "# '*+ 3*:*;<  * *=
48 Poster Presentations

Table 1.
Crude incidence rates and risk of ASCVD in patients with RA by unprovoked VTE.
Events/
Patients

Patient-years

Incidence Rate
(95% CI)*

Unadjusted
(HR (95% CI)

1,283/25,070

147,735

8.68
(8.22-9.17)

-

-

    
VTE (no prior ASCVD or VTE)

38/506

16,152

23.53
(17.12-32.33)

2.50
(1.81-3.44)

2.05
(1.43-2.95)

DVT only

21/325

11,150

18.83
(12.28-28.87)

2.03
(1.32-3.12)

1.93
(1.22-3.06)

Pulmonary emboli

17/181

5,002

33.99
(21.13-54.67)

3.78
(2.50-5.70)

2.52
(1.57-4.04)

Patients without
VTE or ASCVD

 
(95% CI)

*Per 10,000 patient-years
           !"   "
residency), ethnicity, smoking, hypertension ,diabetes, comorbidity index, BMI, HAQ, patient global and
pain scores, glucocorticoid use DMARDs including MTX, HCQ, TNFi and nonTNFi bDMARDs, NSAIDs,
statins, fracture, pulmonary disease, prior count of csDMARDs and bDMARDs, calendar year
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should be evaluated carefully for ASCVD in
the presence of concerning symptoms and
CV risk screening and management should be
optimized. 
https://doi.org/10.32873/unmc.dc.gmerj.2.1.072

Graduate Medical Education Research Journal

